Doliente, Michelle .
HRN: 05-68-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2023
CEFUROXIME 1.5GM (VIAL)
07/12/2023
07/19/2023
IV
1.5
On Call Or
For CS
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes